CBx Sciences Acquiring Evolab's Rights

Denver-based CBx Sciences announced it is acquiring the rights to Evolab’s cannabis brands and product development platform. The company hopes that the move will help it further expand into a global legal cannabis market, one that could be worth more than four times what it’s valued at today.

“CBx Sciences was founded with the goal of advancing the global cannabis industry by creating the most effective products, formulations and technology platforms,” explained CBx Sciences CEO Nicole Smith in a statement. “This arrangement will allow us to bring Evolab’s tried and true, production-level extraction, purification, and manufacturing technology to our partners across the rapidly expanding global cannabis ecosystem.”

As part of the announcement, Evolab will manufacture all of CBx Sciences topical, inhalation and edible products in Colorado for distribution in medical and recreational outlets.

Evolab has a number of products and intellectual property that CBx appears excited about acquiring, noting its extraction, distillation, purification, and manufacturing solutions are “unrivaled in the cannabis industry and will be the cornerstone of many of CBx Sciences’ initial projects.”

The company’s product lines include Chroma, Alchemy, COLORS, and FreshTerps, all of which have reputations “as some of the most innovative cannabis products in the legal market,” according to the company.

Evolab’s products differ from others in the marketplace in that the company produces what it calls “exceptionally pure oils,” but does not use any cutting agents. The company noted its proprietary technology allows them “to preserve the compounds of the whole plant because we know it takes all the elements in cannabis to make THC great.”

In addition to these products, CBx Sciences sells skin repair, body oil and a host of lifestyle products, including t-shirts, water bottles, and other fitness-related apparel.

The legal cannabis-infused products industry is expected to grow by more than three-fold over the next four years, topping $20 billion by 2021, according to data compiled by BDS Analytics. Separately, Brightfield Group, a cannabis investment research firm, puts the international market for cannabis-related products at an expected $31.4 billion by 2021, up from $7.7 billion today.

 

Jack Smith

Jack Smith is a tech reporter that dabbles in cannabis reporting to help out his good friends at GMR.


Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 9 hours

Nevada schools have received $159 million from cannabis taxes in FY21. @ShopPlanet13…

@GreenMarketRpt – 10 hours

Pretty scary results on Delta-8 products by The latest from

@GreenMarketRpt – 1 day

$HYFM Buys IGE but lowers 2021 guidance. “a short-term oversupply has put downward pressure on cannabi…

Back to Top

Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.